Author:
Borgohain Mrinal,Gupta Rahul,Trivedi Sameer,Vaddi SuryaPrakash,Mittal Rajan,Pandit Sucheta,Mane Amey
Reference26 articles.
1. Management of Benign Prostatic Hyperplasia. American Urological Association; 2010. Available from: https://www.auanet.org/guidelines/benign-prostatic-hyperplasia-(bph)-guideline/benign- prostatic-hyperplasia-(2010-reviewed-and-validity -confirmed-2014). [Last accessed on 2021 May 21].
2. Benign prostatic hyperplasia and male lower urinary tract symptoms: Epidemiology and risk factors;Parsons;Curr Bladder Dysfunct Rep,2010
3. EAU Guidelines on benign prostatic hyperplasia (BPH);de;Eur Urol,2001
4. Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck;Caine;Br J Urol,1975
5. Efficacy and safety of sustained-release alfuzosin 5 mg in patients with benign prostatic hyperplasia.ALGEBI Study Group;Buzelin;Eur Urol,1997